Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078470 | SCV000110326 | benign | not specified | 2013-03-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000078470 | SCV000303370 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000625294 | SCV000407871 | benign | Niemann-Pick disease, type C1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625294 | SCV000744748 | benign | Niemann-Pick disease, type C1 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000078470 | SCV001339024 | benign | not specified | 2020-03-02 | criteria provided, single submitter | clinical testing | Variant summary: NPC1 c.1947+14G>T alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.045 in 233216 control chromosomes in the gnomAD database, including 1029 homozygotes. The observed variant frequency is approximately 16-fold the estimated maximal expected allele frequency for a pathogenic variant in NPC1 causing Niemann-Pick Disease Type C phenotype (0.0028), strongly suggesting that the variant is benign. c.1947+14G>T has been reported in the literature in individuals affected with Niemann-Pick Disease Type C (e.g. DeCastro-Oros_2017). These reports do not provide unequivocal conclusions about association of the variant with Niemann-Pick Disease Type C. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Invitae | RCV000625294 | SCV001717267 | benign | Niemann-Pick disease, type C1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000625294 | SCV001737967 | benign | Niemann-Pick disease, type C1 | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000625294 | SCV000745711 | likely benign | Niemann-Pick disease, type C1 | 2016-05-10 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000078470 | SCV001807816 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000078470 | SCV001922945 | benign | not specified | no assertion criteria provided | clinical testing |